|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q85323674
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010736.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q85323674
|
|
024
|
|
|
‡a
0000-0002-0818-273X
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q85323674
|
|
100
|
0 |
|
‡a
Rickey E Carter
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Rickey E Carter
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's 12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia
|
|
670
|
|
|
‡a
Author's 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
|
|
670
|
|
|
‡a
Author's Artificial Intelligence in Cardiology: Present and Future
|
|
670
|
|
|
‡a
Author's Behind the numbers: propensity score analysis-a primer for the diagnostic radiologist
|
|
670
|
|
|
‡a
Author's Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity".
|
|
670
|
|
|
‡a
Author's Comparison of a Photon-Counting-Detector CT with an Energy-Integrating-Detector CT for Temporal Bone Imaging: A Cadaveric Study.
|
|
670
|
|
|
‡a
Author's Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system
|
|
670
|
|
|
‡a
Author's Diurnal pattern to insulin secretion and insulin action in healthy individuals
|
|
670
|
|
|
‡a
Author's Does prediabetes cause small fiber sensory polyneuropathy? Does it matter?
|
|
670
|
|
|
‡a
Author's Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
|
|
670
|
|
|
‡a
Author's Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience
|
|
670
|
|
|
‡a
Author's Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes
|
|
670
|
|
|
‡a
Author's Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function
|
|
670
|
|
|
‡a
Author's Evaluation of Lower-Dose Spiral Head CT for Detection of Intracranial Findings Causing Neurologic Deficits
|
|
670
|
|
|
‡a
Author's Evidence favoring the efficacy of convalescent plasma for COVID-19 therapy
|
|
670
|
|
|
‡a
Author's Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approach
|
|
670
|
|
|
‡a
Author's Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments
|
|
670
|
|
|
‡a
Author's Hyperglycemia But Not Hyperinsulinemia Is Favorable for Exercise in Type 1 Diabetes: A Pilot Study
|
|
670
|
|
|
‡a
Author's Impact of electronic clinical decision support on adherence to guideline-recommended treatment for hyperlipidaemia, atrial fibrillation and heart failure: protocol for a cluster randomised trial.
|
|
670
|
|
|
‡a
Author's Increased Curvature of the Tentorium Cerebelli in Idiopathic Intracranial Hypertension
|
|
670
|
|
|
‡a
Author's Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality
|
|
670
|
|
|
‡a
Author's Intravenous Contrast Material-induced Nephropathy: Causal or Coincident Phenomenon?
|
|
670
|
|
|
‡a
Author's Low-Dose CT for Craniosynostosis: Preserving Diagnostic Benefit with Substantial Radiation Dose Reduction
|
|
670
|
|
|
‡a
Author's Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
|
|
670
|
|
|
‡a
Author's Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches
|
|
670
|
|
|
‡a
Author's Normal-Weight Central Obesity and Mortality Risk in Older Adults With Coronary Artery Disease
|
|
670
|
|
|
‡a
Author's Observer Performance for Detection of Pulmonary Nodules at Chest CT over a Large Range of Radiation Dose Levels
|
|
670
|
|
|
‡a
Author's Point-of-care washing of allogeneic red blood cells for the prevention of transfusion-related respiratory complications (WAR-PRC): a protocol for a multicenter randomised clinical trial in patients undergoing cardiac surgery
|
|
670
|
|
|
‡a
Author's Postprandial glucose fluxes and insulin sensitivity during exercise: a study in healthy individuals
|
|
670
|
|
|
‡a
Author's Pragmatic considerations for fostering reproducible research in artificial intelligence
|
|
670
|
|
|
‡a
Author's Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram
|
|
670
|
|
|
‡a
Author's Response
|
|
670
|
|
|
‡a
Author's Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure
|
|
670
|
|
|
‡a
Author's Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate
|
|
670
|
|
|
‡a
Author's Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram
|
|
670
|
|
|
‡a
Author's Sex differences in youth elite swimming
|
|
670
|
|
|
‡a
Author's The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people
|
|
670
|
|
|
‡a
Author's The evolving role of imaging for small bowel neuroendocrine neoplasms: estimated impact of imaging and disease-free survival in a retrospective observational study
|
|
670
|
|
|
‡a
Author's প্রত্যুত্তর
|
|
909
|
|
|
‡a
(orcid) 000000020818273x
‡9
1
|
|
912
|
|
|
‡a
response
‡A
Response
‡9
1
|
|
912
|
|
|
‡a
পরতযততর
‡A
প্রত্যুত্তর
‡9
1
|
|
919
|
|
|
‡a
12week247ambulatoryartificialpancreaswithweeklyadaptationofinsulindeliverysettingseffectonhemoglobina1candhypoglycemia
‡A
12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia
‡9
1
|
|
919
|
|
|
‡a
2012provisionalclassificationcriteriaforpolymyalgiarheumaticaaeuropeanleagueagainstrheumatismamericancollegeofrheumatologycollaborativeinitiative
‡A
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
‡9
1
|
|
919
|
|
|
‡a
artificialintelligenceincardiologypresentandfuture
‡A
Artificial Intelligence in Cardiology: Present and Future
‡9
1
|
|
919
|
|
|
‡a
behindthenumberspropensityscoreanalysisa1forthediagnosticradiologist
‡A
Behind the numbers: propensity score analysis-a primer for the diagnostic radiologist
‡9
1
|
|
919
|
|
|
‡a
combiningbodymassindexwithmeasuresofcentralobesityintheassessmentofmortalityinsubjectswithcoronarydiseaseroleofnormalweightcentralobesity
‡A
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity".
‡9
1
|
|
919
|
|
|
‡a
comparisonofaphotoncountingdetectorctwithanenergyintegratingdetectorctfortemporalboneimagingacadavericstudy
‡A
Comparison of a Photon-Counting-Detector CT with an Energy-Integrating-Detector CT for Temporal Bone Imaging: A Cadaveric Study.
‡9
1
|
|
919
|
|
|
‡a
diurnalpatternofinsulinactionintype1diabetesimplicationsforaclosedloopsystem
‡A
Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system
‡9
1
|
|
919
|
|
|
‡a
diurnalpatterntoinsulinsecretionandinsulinactioninhealthyindividuals
‡A
Diurnal pattern to insulin secretion and insulin action in healthy individuals
‡9
1
|
|
919
|
|
|
‡a
doesprediabetescausesmallfibersensorypolyneuropathydoesitmatter
‡A
Does prediabetes cause small fiber sensory polyneuropathy? Does it matter?
‡9
1
|
|
919
|
|
|
‡a
earlysafetyindicatorsofcovid19convalescentplasmain5000patients
‡A
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
‡9
1
|
|
919
|
|
|
‡a
effectofconvalescentplasmaonmortalityamonghospitalizedpatientswithcovid19initial3monthexperience
‡A
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience
‡9
1
|
|
919
|
|
|
‡a
effectofpramlintideonpostprandialglucosefluxesintype1diabetes
‡A
Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes
‡9
1
|
|
919
|
|
|
‡a
effectsofdelayedgastricemptyingonpostprandialglucosekineticsinsulinsensitivityandβcellfunction
‡A
Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function
‡9
1
|
|
919
|
|
|
‡a
evaluationoflowerdosespiralheadctfordetectionofintracranialfindingscausingneurologicdeficits
‡A
Evaluation of Lower-Dose Spiral Head CT for Detection of Intracranial Findings Causing Neurologic Deficits
‡9
1
|
|
919
|
|
|
‡a
evidencefavoringtheefficacyofconvalescentplasmaforcovid19therapy
‡A
Evidence favoring the efficacy of convalescent plasma for COVID-19 therapy
‡9
1
|
|
919
|
|
|
‡a
exerciseeffectsonpostprandialglucosemetabolismintype1diabetesatripletracerapproach
‡A
Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approach
‡9
1
|
|
919
|
|
|
‡a
glucagonsensitivityandclearanceintype1diabetesinsightsfrominvivoandinsilicoexperiments
‡A
Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments
‡9
1
|
|
919
|
|
|
‡a
hyperglycemiabutnothyperinsulinemiaisfavorableforexerciseintype1diabetesapilotstudy
‡A
Hyperglycemia But Not Hyperinsulinemia Is Favorable for Exercise in Type 1 Diabetes: A Pilot Study
‡9
1
|
|
919
|
|
|
‡a
impactofelectronicclinicaldecisionsupportonadherencetoguidelinerecommendedtreatmentforhyperlipidaemiaatrialfibrillationandheartfailureprotocolforaclusterrandomisedtrial
‡A
Impact of electronic clinical decision support on adherence to guideline-recommended treatment for hyperlipidaemia, atrial fibrillation and heart failure: protocol for a cluster randomised trial.
‡9
1
|
|
919
|
|
|
‡a
increasedcurvatureofthetentoriumcerebelliinidiopathicintracranialhypertension
‡A
Increased Curvature of the Tentorium Cerebelli in Idiopathic Intracranial Hypertension
‡9
1
|
|
919
|
|
|
‡a
intravenouscontrastmaterialexposureisnotanindependentriskfactorfordialysisormortality
‡A
Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality
‡9
1
|
|
919
|
|
|
‡a
intravenouscontrastmaterialinducednephropathycausalorcoincidentphenomenon
‡A
Intravenous Contrast Material-induced Nephropathy: Causal or Coincident Phenomenon?
‡9
1
|
|
919
|
|
|
‡a
lowdosectforcraniosynostosispreservingdiagnosticbenefitwithsubstantialradiationdosereduction
‡A
Low-Dose CT for Craniosynostosis: Preserving Diagnostic Benefit with Substantial Radiation Dose Reduction
‡9
1
|
|
919
|
|
|
‡a
mortalityinindividualstreatedwithcovid19convalescentplasmavarieswiththegeographicprovenanceofdonors
‡A
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
‡9
1
|
|
919
|
|
|
‡a
nocturnalglucosemetabolismintype1diabetesastudycomparingsingleversusdualtracerapproaches
‡A
Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches
‡9
1
|
|
919
|
|
|
‡a
normalweightcentralobesityandmortalityriskinolderadultswithcoronaryarterydisease
‡A
Normal-Weight Central Obesity and Mortality Risk in Older Adults With Coronary Artery Disease
‡9
1
|
|
919
|
|
|
‡a
observerperformancefordetectionofpulmonarynodulesatchestctoveralargerangeofradiationdoselevels
‡A
Observer Performance for Detection of Pulmonary Nodules at Chest CT over a Large Range of Radiation Dose Levels
‡9
1
|
|
919
|
|
|
‡a
pointofcarewashingofallogeneicredbloodcellsforthepreventionoftransfusionrelatedrespiratorycomplicationswarprcaprotocolforamulticenterrandomisedclinicaltrialinpatientsundergoingcardiacsurgery
‡A
Point-of-care washing of allogeneic red blood cells for the prevention of transfusion-related respiratory complications (WAR-PRC): a protocol for a multicenter randomised clinical trial in patients undergoing cardiac surgery
‡9
1
|
|
919
|
|
|
‡a
postprandialglucosefluxesandinsulinsensitivityduringexerciseastudyinhealthyindividuals
‡A
Postprandial glucose fluxes and insulin sensitivity during exercise: a study in healthy individuals
‡9
1
|
|
919
|
|
|
‡a
pragmaticconsiderationsforfosteringreproducibleresearchinartificialintelligence
‡A
Pragmatic considerations for fostering reproducible research in artificial intelligence
‡9
1
|
|
919
|
|
|
‡a
rapidexclusionofcovidinfectionwiththeartificialintelligenceelectrocardiogram
‡A
Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram
‡9
1
|
|
919
|
|
|
‡a
riskofacutekidneyinjurydialysisandmortalityinpatientswithchronickidneydiseaseafterintravenouscontrastmaterialexposure
‡A
Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure
‡9
1
|
|
919
|
|
|
‡a
riskofintravenouscontrastmaterialmediatedacutekidneyinjuryapropensityscorematchedstudystratifiedbybaselineestimatedglomerularfiltrationrate
‡A
Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate
‡9
1
|
|
919
|
|
|
‡a
screeningforcardiaccontractiledysfunctionusinganartificialintelligenceenabledelectrocardiogram
‡A
Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram
‡9
1
|
|
919
|
|
|
‡a
sexdifferencesinyoutheliteswimming
‡A
Sex differences in youth elite swimming
‡9
1
|
|
919
|
|
|
‡a
effectofwalkingonpostprandialglycemicexcursioninpatientswithtype1diabetesandhealthypeople
‡A
The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people
‡9
1
|
|
919
|
|
|
‡a
evolvingroleofimagingforsmallbowelneuroendocrineneoplasmsestimatedimpactofimaginganddiseasefreesurvivalinaretrospectiveobservationalstudy
‡A
The evolving role of imaging for small bowel neuroendocrine neoplasms: estimated impact of imaging and disease-free survival in a retrospective observational study
‡9
1
|
|
996
|
|
|
‡2
NII|DA02764425
|
|
996
|
|
|
‡2
PTBNP|190653
|
|
996
|
|
|
‡2
ISNI|0000000000191848
|
|
996
|
|
|
‡2
J9U|987007324732805171
|
|
996
|
|
|
‡2
CAOONL|ncf11896548
|
|
996
|
|
|
‡2
LC|n 86864531
|
|
996
|
|
|
‡2
LC|no 97005583
|
|
996
|
|
|
‡2
NTA|097537713
|
|
996
|
|
|
‡2
BIBSYS|14024711
|
|
996
|
|
|
‡2
ISNI|0000000046024236
|
|
996
|
|
|
‡2
ISNI|0000000048138739
|
|
996
|
|
|
‡2
BNF|12569166
|
|
996
|
|
|
‡2
J9U|987007356490605171
|
|
996
|
|
|
‡2
ISNI|0000000019766293
|
|
996
|
|
|
‡2
ISNI|0000000395242426
|
|
996
|
|
|
‡2
ISNI|0000000053290153
|
|
996
|
|
|
‡2
LC|n 89118232
|
|
996
|
|
|
‡2
J9U|987007318061605171
|
|
996
|
|
|
‡2
ISNI|0000000069914020
|
|
996
|
|
|
‡2
RERO|A003080366
|
|
996
|
|
|
‡2
J9U|987007459617805171
|
|
996
|
|
|
‡2
NTA|096412836
|
|
996
|
|
|
‡2
ISNI|0000000095887046
|
|
996
|
|
|
‡2
BIBSYS|90346529
|
|
996
|
|
|
‡2
RERO|A003080369
|
|
996
|
|
|
‡2
RERO|A003080368
|
|
996
|
|
|
‡2
PTBNP|1689969
|
|
996
|
|
|
‡2
NII|DA05081247
|
|
996
|
|
|
‡2
ISNI|0000000075614331
|
|
996
|
|
|
‡2
CAOONL|ncf10483948
|
|
996
|
|
|
‡2
LC|n 87129907
|
|
996
|
|
|
‡2
J9U|987007330181605171
|
|
996
|
|
|
‡2
DNB|1089788282
|
|
996
|
|
|
‡2
J9U|987007316205005171
|
|
996
|
|
|
‡2
LC|n 00008470
|
|
996
|
|
|
‡2
DNB|12864320X
|
|
996
|
|
|
‡2
BIBSYS|90556113
|
|
996
|
|
|
‡2
CAOONL|ncf10477198
|
|
996
|
|
|
‡2
LC|n 85356056
|
|
996
|
|
|
‡2
LC|no 98093521
|
|
996
|
|
|
‡2
PLWABN|9810699321705606
|
|
996
|
|
|
‡2
NTA|071961224
|
|
996
|
|
|
‡2
BIBSYS|90784424
|
|
996
|
|
|
‡2
NKC|xx0077733
|
|
996
|
|
|
‡2
LC|no2015120528
|
|
996
|
|
|
‡2
ISNI|000000045219808X
|
|
996
|
|
|
‡2
LC|n 96046044
|
|
996
|
|
|
‡2
ISNI|0000000041726714
|
|
996
|
|
|
‡2
BIBSYS|90658442
|
|
996
|
|
|
‡2
LC|no 98007264
|
|
996
|
|
|
‡2
RERO|A016354561
|
|
996
|
|
|
‡2
SUDOC|035000597
|
|
996
|
|
|
‡2
BIBSYS|90878137
|
|
996
|
|
|
‡2
NLA|000035856944
|
|
996
|
|
|
‡2
LC|no2011034881
|
|
996
|
|
|
‡2
LC|no 98029946
|
|
996
|
|
|
‡2
LC|no2010035540
|
|
996
|
|
|
‡2
CAOONL|ncf11190753
|
|
996
|
|
|
‡2
LC|no2003106011
|
|
996
|
|
|
‡2
RERO|A003080370
|
|
996
|
|
|
‡2
ISNI|0000000042688377
|
|
996
|
|
|
‡2
BIBSYS|90363498
|
|
996
|
|
|
‡2
SUDOC|092638716
|
|
996
|
|
|
‡2
CAOONL|ncf11038143
|
|
996
|
|
|
‡2
ISNI|0000000081722478
|
|
996
|
|
|
‡2
LC|n 87884600
|
|
996
|
|
|
‡2
DNB|139937994
|
|
996
|
|
|
‡2
SUDOC|115509844
|
|
996
|
|
|
‡2
SUDOC|198487339
|
|
996
|
|
|
‡2
ISNI|0000000066697382
|
|
996
|
|
|
‡2
NTA|400886995
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
